Quantum Healthcare Limited (SGX:V8Y)
Singapore · Delayed Price · Currency is SGD 0.0010
-0.0010 (-50.00%)
At close: Aug 14, 2026
Quantum Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13.21 | 13.06 | 12.69 | 13.08 | 9.37 | - | |
Revenue Growth | 2.08% | 2.99% | -3.03% | 39.63% | 1172.43% | - |
Cost of Revenue | 7.27 | 7.13 | 7.03 | 7.32 | 5.02 | - |
Gross Profit | 5.94 | 5.93 | 5.66 | 5.76 | 4.35 | - |
Selling, General & Admin | 6.36 | 6.46 | 6.89 | 8.73 | 6.61 | 3.26 |
Research & Development | - | - | - | - | 0.74 | - |
Other Operating Expenses | -0.2 | -0.21 | -0.16 | -0.18 | -0.09 | 0 |
Operating Expenses | 6.16 | 6.24 | 6.73 | 8.55 | 7.27 | 3.26 |
Operating Income | -0.22 | -0.31 | -1.08 | -2.79 | -2.92 | -3.26 |
Interest Expense | -0.3 | -0.35 | -0.46 | -0.49 | -0.45 | -0.03 |
Currency Exchange Gain (Loss) | - | - | - | - | -0 | -0.04 |
EBT Excluding Unusual Items | -0.52 | -0.66 | -1.54 | -3.28 | -3.37 | -3.34 |
Impairment of Goodwill | -2.19 | -2.19 | -1.01 | - | -4.63 | - |
Gain (Loss) on Sale of Assets | 0 | 0 | 0.02 | - | -0.79 | 0.14 |
Asset Writedown | - | - | - | - | - | -2.11 |
Other Unusual Items | 0 | 0 | - | - | - | - |
Pretax Income | -2.71 | -2.85 | -2.52 | -3.28 | -8.78 | -5.31 |
Income Tax Expense | 0.05 | 0.07 | 0.04 | 0.1 | 0.12 | - |
Earnings From Continuing Operations | -2.76 | -2.91 | -2.56 | -3.38 | -8.9 | -5.31 |
Minority Interest in Earnings | 0.05 | 0.17 | 0.33 | -0.24 | -0.17 | 0.03 |
Net Income | -2.71 | -2.74 | -2.23 | -3.62 | -9.07 | -5.28 |
Net Income to Common | -2.71 | -2.74 | -2.23 | -3.62 | -9.07 | -5.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 10,575 | 8,289 | 7,947 | 7,327 | 6,751 | 2,260 |
Shares Outstanding (Diluted) | 10,575 | 8,289 | 7,947 | 7,327 | 6,751 | 2,260 |
Shares Change | 31.95% | 4.30% | 8.46% | 8.53% | 198.73% | 4.08% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 0.94 | 1.89 | 1.1 | -0.93 | -2.23 | -1.3 |
Free Cash Flow Per Share | - | - | - | - | - | -0.00 |
Gross Margin | 44.99% | 45.41% | 44.60% | 44.03% | 46.42% | - |
Operating Margin | -1.65% | -2.39% | -8.48% | -21.34% | -31.14% | - |
Profit Margin | -20.49% | -21.00% | -17.61% | -27.68% | -96.78% | - |
Free Cash Flow Margin | 7.12% | 14.47% | 8.63% | -7.08% | -23.76% | - |
EBITDA | 0.24 | 0.24 | -0.56 | -2.31 | -2.59 | -3.17 |
EBITDA Margin | 1.84% | 1.80% | -4.38% | -17.68% | -27.62% | - |
D&A For EBITDA | 0.46 | 0.55 | 0.52 | 0.48 | 0.33 | 0.09 |
EBIT | -0.22 | -0.31 | -1.08 | -2.79 | -2.92 | -3.26 |
EBIT Margin | -1.65% | -2.39% | -8.48% | -21.34% | -31.14% | - |